Alvotech og Teva Pha
Alvotech og Teva Pharmaceuticals hefja sölu á líftæknilyfjahliðstæðunni Simlandi í Bandaríkjunum
May 20, 2024 20:25 ET | Alvotech
Simlandi er fyrsta líftæknilyfjahliðstæðan í háum styrk með útskiptanleika við Humira á markaði í Bandaríkjunum Alvotech (NASDAQ: ALVO) og samstarfsaðili þess Teva Pharmaceuticals Ltd. tilkynntu í...
Alvotech_logo.jpg
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
May 20, 2024 20:25 ET | Alvotech
SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S....
Hi ECARX20221221-204233.png
ECARX Announces First Quarter 2024 Unaudited Financial Results
May 20, 2024 07:00 ET | ECARX LIMITED
Exhibit 99.1 SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial...
sphericalinsightsoptionblue.png
Global Cookies Market Size To Worth USD 52.98 Billion By 2033 | CAGR Of 6.9%
May 16, 2024 16:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , May 16, 2024 (GLOBE NEWSWIRE) -- The Global Cookies Market Size is to Grow from USD 27.08 Billion in 2023 to USD 52.98 Billion by 2033, at a Compound Annual Growth Rate...
BGG Logo.jpg
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
May 14, 2024 04:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
UNCY Logo.jpg
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update
May 13, 2024 16:16 ET | Unicycive Therapeutics, Inc.
– On Track to Provide Topline Data from the Ongoing Pivotal Clinical Trial with Oxylanthanum Carbonate (OLC) in Q2 2024 – – Multiple Presentations on OLC and UNI-494 at Prominent, Upcoming Medical...
Alvotech_logo.jpg
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
May 13, 2024 08:00 ET | Alvotech
REYKJAVIK, Iceland, May 13, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
Alvotech_logo.jpg
Alvotech kynnir uppgjör fyrsta ársfjórðungs 2024 22. maí nk. kl. 12 að íslenskum tíma
May 13, 2024 08:00 ET | Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrsta ársfjórðungs 2024 eftir lokun markaða í Bandaríkjunum, þriðjudaginn 21. maí nk.  Þá mun Alvotech halda kynningarfund fyrir...
Alvotech_logo.jpg
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
May 13, 2024 08:00 ET | Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results...
scorpio.png
Scorpio Tankers Inc. Announces Financial Results for the First Quarter of 2024 and Declaration of a Dividend
May 09, 2024 06:44 ET | Scorpio Tankers Inc.
MONACO, May 09, 2024 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) ("Scorpio Tankers" or the "Company") today reported its results for the three months ended March 31, 2024. The Company...